Equifax EVP buys 2,400 shares at $193.72

Equifax executive vice president and Chief Product Officer Cecilia Mao bought 2,400 shares of EQUIFAX INC common stock in an open-market transaction at $193.72 per share.

Rhea-AI Filing Summary

Equifax executive vice president and Chief Product Officer Cecilia Mao bought 2,400 shares of EQUIFAX INC common stock in an open-market transaction at $193.72 per share. After this purchase, she directly owns 10,623 common shares, increasing her personal equity stake in the company.

Insider Trade Summary

Net Buyer: 2,400 shares

Net Buy 1 txn

Insider Mao Cecilia

Role EVP, Chief Product Officer

Bought 2,400 shs ($465K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	2,400	$193.72	$465K

Holdings After Transaction: Common Stock — 10,623 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/18/2025.
2. F2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Equifax (EFX) executive Cecilia Mao report?

Cecilia Mao reported buying 2,400 shares of Equifax common stock in an open-market transaction. The shares were purchased at a price of $193.72 per share, reflecting an increase in her direct equity ownership in the company.

At what price did Cecilia Mao buy Equifax (EFX) shares in the latest Form 4?

She purchased the Equifax common shares at $193.72 per share. This per-share price applies to all 2,400 shares reported in the transaction, indicating a meaningful personal investment at a relatively high absolute stock price level.

How many Equifax (EFX) shares does Cecilia Mao own after this Form 4 transaction?

Following the reported purchase, Cecilia Mao directly owns 10,623 shares of Equifax common stock. This updated ownership figure reflects her holdings after adding the 2,400 shares bought in the open-market transaction disclosed in the Form 4.

What role does Cecilia Mao hold at Equifax (EFX) in this Form 4 filing?

Cecilia Mao is listed as Executive Vice President and Chief Product Officer of Equifax. Her senior leadership role means this open-market stock purchase aligns her financial interests more closely with company performance through increased direct share ownership.

Was the Equifax (EFX) insider transaction by Cecilia Mao a purchase or a sale?

The transaction was a purchase of Equifax common stock. The Form 4 shows a code "P" and describes it as an open-market purchase, indicating she acquired 2,400 additional shares rather than selling existing holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 04:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mao Cecilia

(Last) (First) (Middle)

1550 PEACHTREE STREET, N.W.

(Street)

ATLANTA GA 30309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EQUIFAX INC [ EFX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Product Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/18/2026		P(1)		2,400	A	$193.72	10,623(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/18/2025.

2. Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.

	/s/Lisa Stockard as Attorney-in-Fact	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.